Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)

China · Delayed Price · Currency is CNY

29.72

-2.54 (-7.87%)

Apr 10, 2026, 11:00 AM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Medical Instruments		464.92M	494.65M	407.64M	456.56M	489.84M
Medical Instruments Growth		-6.01%	21.35%	-10.72%	-6.79%	-28.54%
Pharmaceutical Divison		978.45M	735.81M	1.08B	999.38M	984.52M
Pharmaceutical Divison Growth		32.98%	-31.56%	7.57%	1.51%	9.83%
Medicine Circulation		-	226.62M	231.30M	-	-
Medicine Circulation Growth		-	-2.02%	-	-	-
Other Business		-	84.87M	72.42M	474.66M	35.01M
Other Business Growth		-	17.18%	-84.74%	1255.64%	-32.06%
Aluminum Products		-	-	-	-	2.87B
Aluminum Products Growth		-	-	-	-	-0.87%
Metals Trading		-	-	-	-	9.33B
Metals Trading Growth		-	-	-	-	-23.34%
Total		1.44B	1.54B	1.79B	1.93B	13.70B
Total Growth		-6.39%	-13.69%	-7.47%	-85.91%	-17.91%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China		1.13B	1.19B	1.49B	1.60B	13.35B
China Growth		-5.36%	-20.03%	-6.63%	-88.04%	-17.41%
Overseas		315.31M	350.04M	295.99M	334.36M	353.05M
Overseas Growth		-9.92%	18.26%	-11.48%	-5.29%	-33.16%
Total		1.44B	1.54B	1.79B	1.93B	13.70B
Total Growth		-6.39%	-13.69%	-7.47%	-85.91%	-17.91%

Source: S&P Global Market Intelligence.